124 related articles for article (PubMed ID: 4360619)
21. Serum relaxin in patients with invasive mole, choriocarcinoma and persistent trophoblastic disease.
Seki K; Uesato T; Kato K
Endocrinol Jpn; 1986 Oct; 33(5):727-33. PubMed ID: 3030714
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of serum progesterone during treatment of malignant trophoblastic disease.
Dawood MY
Am J Obstet Gynecol; 1975 Oct; 123(3):291-8. PubMed ID: 170826
[TBL] [Abstract][Full Text] [Related]
23. Plasma beta-subunit human chorionic gonadotropin assay in molar pregnancy and choriocarcinoma.
Yuen BH; Cannon W; Benedet JL; Boyes DA
Am J Obstet Gynecol; 1977 Apr; 127(7):711-2. PubMed ID: 557901
[TBL] [Abstract][Full Text] [Related]
24. Laboratory assessment of disappearance patterns of human chorionic gonadotropin from serum of patients with gestational trophoblastic disease.
Boots LR; Hatch KD; Younger JB
Ala J Med Sci; 1983 Oct; 20(4):391-4. PubMed ID: 6316799
[No Abstract] [Full Text] [Related]
25. A rapid solid-phase radioimmunoassay specific for human chorionic gonadotropin in gestational trophoblastic disease.
Goldstein DP; Pastorfide GB; Osathanondh R; Kosasa TS
Obstet Gynecol; 1975 May; 45(5):527-30. PubMed ID: 164644
[TBL] [Abstract][Full Text] [Related]
26. Radioimmunoassay of serum chorionic gonadotropin and placental lactogen in trophoblastic disease.
Yen SS; Pearson OH; Rankin JS
Obstet Gynecol; 1968 Jul; 32(1):86-93. PubMed ID: 4316070
[No Abstract] [Full Text] [Related]
27. Serum placental lactogen activity in patients with molar pregnancy and trophoblastic tumors--a reliable index of malignancy.
Goldstein DP
Am J Obstet Gynecol; 1971 Jun; 110(4):583-7. PubMed ID: 4325820
[No Abstract] [Full Text] [Related]
28. [HCG in patients with hydatidiform mole or chorionepithelioma].
Rjosk HK; Gokel JM; Holzmann K
Arch Gynecol; 1979 Jul; 228(1-4):667-8. PubMed ID: 485551
[No Abstract] [Full Text] [Related]
29. The hCG assay in the treatment of trophoblastic disease.
Pattillo RA; Hussa RO
J Reprod Med; 1984 Nov; 29(11):802-12. PubMed ID: 6097684
[TBL] [Abstract][Full Text] [Related]
30. Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma.
Kohorn EI
Gynecol Oncol; 2002 May; 85(2):315-20. PubMed ID: 11972394
[TBL] [Abstract][Full Text] [Related]
31. [Fluctuations of plasma progesterone, 17alpha-OH-progesterone and estrogens in trophoblastic diseases (author's transl)].
Miyamoto T
Nihon Naibunpi Gakkai Zasshi; 1977 Mar; 53(3):203-20. PubMed ID: 199477
[No Abstract] [Full Text] [Related]
32. The beta-subunit of chorionic gonadotrophin as a tumour marker in gestational trophoblastic disease.
Khoo SK; Daunter B
Aust N Z J Obstet Gynaecol; 1980 Feb; 20(1):35-42. PubMed ID: 6248013
[TBL] [Abstract][Full Text] [Related]
33. Plasma androstenedione (A) and dihydrotesto-terone (DHT) in patients with trophoblastic disease and the effect of chemotherapy and oophorectomy.
Samaan NA; Smith JP; Rutledge FN
Gynecol Invest; 1973; 4(5-6):237-42. PubMed ID: 4373314
[No Abstract] [Full Text] [Related]
34. The clinical evaluation of the simultaneous measurements of human chorionic gonadotropin (hCG) and its alpha-subunit in sera of patients with trophoblastic diseases.
Nishimura R; Ashitaka Y; Tojo S
Endocrinol Jpn; 1979 Oct; 26(5):575-83. PubMed ID: 527560
[TBL] [Abstract][Full Text] [Related]
35. [Diagnostic value of determining chorionic gonadotropin and trophoblastic beta 1-glycoprotein in trophoblastic disease].
Grinevich IuA; Tatarinov IuS; Iugrinova LG; Olefirenko GA; Dotsenko IuS
Vopr Onkol; 1981; 27(12):19-23. PubMed ID: 6275607
[TBL] [Abstract][Full Text] [Related]
36. Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma.
Dawood MY; Saxena BB; Landesman R
Obstet Gynecol; 1977 Aug; 50(2):172-81. PubMed ID: 195242
[TBL] [Abstract][Full Text] [Related]
37. Serum placental lactogen levels in patients with molar pregnancy and trophoblastic tumors.
Saxena B; Goldstein DP; Emerson K; Selenkow HA
Am J Obstet Gynecol; 1968 Sep; 102(1):115-21. PubMed ID: 4299677
[No Abstract] [Full Text] [Related]
38. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
Zhang WY
Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
[TBL] [Abstract][Full Text] [Related]
39. Serum progesterone and serum chorionic gonadotrophin in hydatidiform mole and choriocarcinoma.
Teoh ES; Das NP; Dawood MY; Ratnam SS
Acta Endocrinol (Copenh); 1972 Aug; 70(4):791-800. PubMed ID: 5068403
[No Abstract] [Full Text] [Related]
40. Placental proteins (SP1, hCG, PP5) and alpha 2-PAG in trophoblastic diseases.
Than GN; Bohn H; Csaba IF; Szabó DG; Karg NJ; Göcze P
Arch Gynecol; 1981; 231(1):33-9. PubMed ID: 6174083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
